The Oncology Institute Inc. (TOIIW) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for The Oncology Institute Inc. (TOIIW:NASDAQ), powered by AI.

Current Price
$0.04
Sector
Healthcare
What is the The Oncology Institute Inc. stock price forecast?

The Oncology Institute Inc. is currently trading at $0.04. View real-time AI analysis on Alpha Lenz.

What is The Oncology Institute Inc. insider trading activity?

View the latest insider trading data for The Oncology Institute Inc. on Alpha Lenz.

What is The Oncology Institute Inc.'s P/E ratio?

View The Oncology Institute Inc.'s valuation metrics on Alpha Lenz.

The Oncology Institute Inc.

NASDAQ · TOIIW
$0.04-0.01(-22.73%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about The Oncology Institute Inc.'s future dividend policy...
Alpha Chat Insight

The Oncology Institute Inc.'s ROE is 999.2%. Explore profitability and growth together.

Ask for details

Company Overview

The Oncology Institute Inc. is a healthcare service provider focused on delivering comprehensive, community-based cancer care. The primary function of this company is to ensure accessible and personalized oncology treatment, aiming to improve patient outcomes through a multidisciplinary approach. The Institute specializes in various oncology disciplines, providing services, including chemotherapy management, radiation therapy, clinical trials, and palliative care. Its operations are instrumental in serving a growing patient population with cutting-edge treatment solutions and enhancing oncological research advancements. The role of The Oncology Institute in the financial market is significant due to its potential in addressing the rising demand for cancer treatment in the healthcare sector. By implementing an integrated care model, it impacts both national healthcare policies and local patient communities, aiming to expand access to high-quality cancer care across various geographical regions.

CEODr. Daniel Virnich FACHE, M.B.A., M.D.
SectorHealthcare
IndustryMedical Care Facilities
Employees825

Company Statistics

FY 2025

Profile

N/AMarket Cap
$502.73MRevenue
0.00Shares Out
825Employees

Margins

15.20%Gross
-5.98%EBITDA
-7.18%Operating
-12.08%Pre-Tax
-12.06%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

25.81%Rev 3Yr
21.80%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-35.93%ROA
999.19%ROE
-29.32%ROIC

Financial Health

$33.56MCash & Cash Equivalents
$146.81MNet Debt
-1147.43%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

The Oncology Institute Inc. (ticker: TOIIW) is a company listed on NASDAQ in the Healthcare sector (Medical Care Facilities). It has approximately 825 employees.

The current price is $0.043 with a P/E ratio of -x and P/B of -x.

ROE is 999.19% and operating margin is -7.18%. Annual revenue is $503M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
The Oncology Institute Inc. (TOIIW) Stock Forecast 2026 $0.04 — Price, Financials & Analyst Targets | Alpha Lenz